Works matching AU Zhou, Yuhong

Results: 170
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Comparison of anti-thymocyte globulin-based immunosuppressive therapy and allogeneic hematopoietic stem cell transplantation in patients with transfusion-dependent non-severe aplastic anaemia: a retrospective study from a single centre.

    Published in:
    Annals of Medicine, 2023, v. 55, n. 2, p. 1, doi. 10.1080/07853890.2023.2271475
    By:
    • Shen, Yingying;
    • Li, Yuzhu;
    • Liu, Qi;
    • Liu, Wenbin;
    • Yu, Qinghong;
    • Hu, Huijin;
    • Liu, Shan;
    • Dong, Jingjie;
    • Xu, Min;
    • Hong, Yaonan;
    • Chen, Ying;
    • Deng, Shu;
    • Zhuang, Haifeng;
    • Hu, Zhiping;
    • Lin, Shenyun;
    • Shen, Yiping;
    • Shen, Jianping;
    • Zhou, Yuhong;
    • Ye, Baodong;
    • Wu, Dijiong
    Publication type:
    Article
    33
    34
    35
    36

    Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study.

    Published in:
    Annals of Hematology, 2023, v. 102, n. 3, p. 503, doi. 10.1007/s00277-023-05086-9
    By:
    • Shen, Yingying;
    • Liu, Qi;
    • Li, Hangchao;
    • Liu, Wenbin;
    • Hu, Huijin;
    • Zhao, Yuechao;
    • Li, Yuzhu;
    • Chen, Ying;
    • Liu, Shan;
    • Yu, Qinghong;
    • Zhuang, Haifeng;
    • Wu, Liqiang;
    • Hu, Zhiping;
    • Zheng, Zhiyin;
    • Shen, Jianping;
    • Lin, Shenyun;
    • Shen, Yiping;
    • Zhou, Yuhong;
    • Ye, Baodong;
    • Wu, Dijiong
    Publication type:
    Article
    37
    38
    39
    40
    41
    42

    Proteogenomic insights into the biology and treatment of pan-melanoma.

    Published in:
    Cell Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41421-024-00688-7
    By:
    • Xiang, Hang;
    • Luo, Rongkui;
    • Wang, Yunzhi;
    • Yang, Bing;
    • Xu, Sha;
    • Huang, Wen;
    • Tang, Shaoshuai;
    • Fang, Rundong;
    • Chen, Lingli;
    • Zhu, Na;
    • Yu, Zixiang;
    • Akesu, Sujie;
    • Wei, Chuanyuan;
    • Xu, Chen;
    • Zhou, Yuhong;
    • Gu, Jianying;
    • Zhao, Jianyuan;
    • Hou, Yingyong;
    • Ding, Chen
    Publication type:
    Article
    43
    44
    45
    46
    47
    48

    The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity.

    Published in:
    Cancer Biology & Therapy, 2013, v. 14, n. 11, p. 1, doi. 10.4161/cbt.26106
    By:
    • Lin, Jianmin;
    • Spidel, Jared L.;
    • Maddage, Christopher J.;
    • Rybinski, Katherine A.;
    • Kennedy, Rina P.;
    • Krauthauser, Candice L. M.;
    • Park, Young Chul;
    • Albone, Earl F.;
    • Jacob, Sara;
    • Goserud, Matthew T.;
    • Martinez, Bryon P.;
    • Chao, Qimin;
    • Zhou, Yuhong;
    • Nicolaides, Nicholas C.;
    • Kline, J. Bradford;
    • Grasso, Luigi
    Publication type:
    Article
    49
    50